Reaction
Corneal Deposits reporting signals
As of the last recalculation, Corneal Deposits appears in 727 FAERS reports alongside 20 co-occurring drug terms. The strongest observed disproportionality signal is CENEGERMIN-BKBJ (PRR 186.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Cenegermin-Bkbj | 71 | 186.2 | 187.3 |
| Timolol Maleate | 43 | 132.0 | 132.6 |
| Prednisolone Acetate | 33 | 95.6 | 95.9 |
| Cefuroxime | 23 | 59.4 | 59.6 |
| Moxifloxacin | 27 | 57.0 | 57.1 |
| Amiodarone Hydrochloride | 21 | 55.2 | 55.3 |
| Moxifloxacin Hydrochloride | 35 | 51.9 | 52.0 |
| Dorzolamide Hydrochloride And Timolol Maleate | 8 | 29.3 | 29.3 |
| Asfotase Alfa | 10 | 29.0 | 29.0 |
| Brimonidine Tartrate | 16 | 26.3 | 26.3 |
| Brinzolamide | 7 | 23.3 | 23.3 |
| Carboxymethylcellulose Sodium | 7 | 21.5 | 21.5 |
| Gentamicin | 9 | 19.9 | 19.9 |
| Timolol | 8 | 19.2 | 19.2 |
| Latanoprost | 29 | 17.1 | 17.2 |
| Aflibercept | 18 | 16.9 | 16.9 |
| Faricimab | 4 | 14.2 | 14.2 |
| Brentuximab Vedotin | 5 | 14.1 | 14.1 |
| Ado-Trastuzumab Emtansine | 4 | 13.7 | 13.7 |
| Lifitegrast | 3 | 5.3 | 5.3 |